Related Experiment Videos
The role of RBC transfusion in the premature infant
American Journal of Diseases of Children (1960)
|September 1, 1984
Summary
Routine red blood cell (RBC) transfusions do not benefit premature infants. This study found no clinical advantage in keeping hemoglobin levels above 10.0 g/dL for growing premature infants.
Area of Science:
- Neonatology
- Pediatric Hematology
- Critical Care Medicine
Background:
- Premature infants often require red blood cell (RBC) transfusions due to anemia.
- Current transfusion guidelines vary, with some advocating for higher hemoglobin thresholds.
Purpose of the Study:
- To evaluate the clinical efficacy of maintaining a higher hemoglobin threshold (above 10.0 g/dL) versus transfusing only for clinical indications in premature infants.
Main Methods:
- Randomized controlled trial involving 56 premature infants (mean gestational age 30 weeks).
- Two groups: transfusion group (hemoglobin > 10.0 g/dL) and nontransfusion group (transfused for clinical indications).
- Longitudinal follow-up included weekly laboratory tests and assessments of clinical outcomes.
Main Results:
- No significant differences in birth weight, gestational age, or initial hemoglobin levels between groups.
- Laboratory differences were observed at discharge, but no significant clinical differences were found.
- No clinical advantage was identified for routine "booster" RBC transfusions.
Conclusions:
- Maintaining a hemoglobin level above 10.0 g/dL through routine transfusions offers no discernible clinical benefit for growing premature infants compared to transfusing based on clinical need.
- These findings suggest that current transfusion practices for premature infants may not require adjustment to higher hemoglobin thresholds.